If you’re preparing to sell a home care, home health, or hospice agency, choosing your M&A advisor is the single highest-leverage decision you’ll make — often worth more to your final outcome than a full year of EBITDA. This guide compares the most established firms in the space, honestly, including ourselves.
Full disclosure: this article is published by Hendon Partners. We’ve done our best to represent every firm below fairly and factually, because sellers who compare advisors carefully tend to become our best-fit clients — and because you should interview more than one firm regardless of what any of us say.
Before the list, the criteria. Five questions separate specialists from generalists:
| Firm | Sector Focus | Representation | Notable Facts |
|---|---|---|---|
| Hendon Partners | Home care, home health, hospice, behavioral health, IDD, staffing | Sell-side & buy-side | 150+ closed transactions; 60–120 day typical close; operator-founded |
| Mertz Taggart | Home-based care, behavioral health, specialty healthcare | Primarily sell-side; runs buyer registration | 20+ years; publishes quarterly M&A reports |
| Stoneridge Partners | Home care, home health, hospice, behavioral health | Both buyers and sellers | 25+ years; 400+ deals closed |
| The Braff Group | Behavioral health, home health/hospice, HME, infusion, staffing | Sell-side focused | ~400 transactions; $5B+ aggregate deal value; 28 years |
| VERTESS | Broad healthcare (DME, IDD, pharmacy, behavioral, home health) | Both buyers and sellers | Ranked #1 on Axial’s Healthcare Top 50; broad vertical coverage |
| Agenda Health | Home care, home health, hospice | Sell-side focused | Texas-based; focused on lower middle market agencies |
| American HealthCare Capital | Broad healthcare | Both buyers and sellers | High listing volume; marketplace-style model |
We are the most narrowly focused firm on this list: home-based care is not one of our verticals — it’s the business. Founded by a former home care operator, with 150+ closed transactions and a typical engagement-to-close of 60–120 days, among the fastest in the industry. We advise sellers through confidential, competitive processes and work with qualified buyers seeking acquisitions in home care, home health, and hospice — never on both sides of the same transaction. Best fit: owners of home care, home health, hospice, behavioral health, or IDD agencies with roughly $500K–$10M in EBITDA who want a competitive, confidential process, and institutional buyers looking for proprietary deal flow in home-based care.
A well-regarded, long-standing healthcare M&A firm with strong research output — their quarterly home-based care M&A reports are widely read. They maintain a buyer registration program, which deepens their buyer network. Good fit for owners who value a firm with heavy publishing presence and 20+ years of history.
One of the oldest names in home care brokerage, with 25+ years and 400+ closed deals across home care, home health, hospice, and behavioral health. Stoneridge works with both buyers and sellers, so ask directly how they handle situations where an acquirer is also a client.
A Pittsburgh-based sell-side firm with nearly 400 transactions and deep experience in behavioral health, HME, and home health/hospice. Braff publishes strong market research (“Braff Reports”) and reports achieving premiums over market indicators. Strong fit for larger, complex deals, particularly in behavioral health.
The broadest generalist on this list — covering everything from veterinary and dental to home health and IDD. VERTESS works both sides of transactions. Their breadth is an asset if your business spans multiple verticals; sector-specific depth in home care specifically is comparatively thinner than the focused firms above.
Both serve the smaller end of the market. Agenda Health focuses on home care/hospice sell-side work in the lower middle market. American HealthCare Capital runs a higher-volume, marketplace-style model — more listings, less bespoke process. For agencies under ~$300K EBITDA, these models can be appropriate; above that, a full competitive process typically recovers the fee difference several times over.
Any firm worth hiring will answer all five without hesitation.
Considering a sale? Book a free, confidential valuation call — 20 minutes, no obligation, and you’ll leave knowing what your agency is worth in today’s market whether or not you ever work with us.
Home Care vs. Home Health vs. Hospice: EBITDA Multiples Compared (2026)
Seller GuidesHow Much Does It Cost to Sell a Home Care Agency? Broker Fees & Commissions Explained (2026)
Seller GuidesCan You Sell a Home Care Agency Without a Broker? Yes — Here's Exactly How (and When You Shouldn't)
State GuidesSelling a Home Care Agency in Colorado: 2026 Market Guide
State GuidesSelling a Home Care Agency in Illinois: 2026 Market Guide
State GuidesSelling a Home Care Agency in Massachusetts: 2026 Market Guide
Newsletter
Receive new articles, EBITDA benchmark updates, and deal intelligence directly in your inbox. No spam — unsubscribe anytime.
Join 1,200+ home care executives. Unsubscribe anytime.